CN116650599A - 一种化湿通痹的中药组合物 - Google Patents
一种化湿通痹的中药组合物 Download PDFInfo
- Publication number
- CN116650599A CN116650599A CN202310801214.8A CN202310801214A CN116650599A CN 116650599 A CN116650599 A CN 116650599A CN 202310801214 A CN202310801214 A CN 202310801214A CN 116650599 A CN116650599 A CN 116650599A
- Authority
- CN
- China
- Prior art keywords
- parts
- traditional chinese
- chinese medicine
- medicine composition
- arthralgia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 100
- 208000006820 Arthralgia Diseases 0.000 title claims abstract description 83
- 239000000203 mixture Substances 0.000 title claims abstract description 49
- 241000903946 Clematidis Species 0.000 claims abstract description 28
- 244000077995 Coix lacryma jobi Species 0.000 claims abstract description 28
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 28
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 28
- 241001673966 Magnolia officinalis Species 0.000 claims abstract description 28
- 244000153955 Reynoutria sachalinensis Species 0.000 claims abstract description 28
- 235000003202 Reynoutria sachalinensis Nutrition 0.000 claims abstract description 28
- 240000004980 Rheum officinale Species 0.000 claims abstract description 28
- 235000008081 Rheum officinale Nutrition 0.000 claims abstract description 28
- 241001369613 Stephania tetrandra Species 0.000 claims abstract description 26
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 24
- 235000011477 liquorice Nutrition 0.000 claims abstract description 24
- 239000000463 material Substances 0.000 claims abstract description 20
- 201000001881 impotence Diseases 0.000 abstract description 49
- 208000010228 Erectile Dysfunction Diseases 0.000 abstract description 28
- 230000000694 effects Effects 0.000 abstract description 15
- 208000011580 syndromic disease Diseases 0.000 abstract description 8
- 206010033799 Paralysis Diseases 0.000 abstract description 4
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 230000004069 differentiation Effects 0.000 abstract description 2
- 229940079593 drug Drugs 0.000 description 33
- 210000003899 penis Anatomy 0.000 description 29
- 238000003745 diagnosis Methods 0.000 description 25
- 210000000952 spleen Anatomy 0.000 description 24
- 230000006870 function Effects 0.000 description 21
- 235000019640 taste Nutrition 0.000 description 16
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 14
- 230000001568 sexual effect Effects 0.000 description 14
- 241000700159 Rattus Species 0.000 description 13
- 230000001737 promoting effect Effects 0.000 description 13
- 230000010415 tropism Effects 0.000 description 12
- 239000008280 blood Substances 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 239000011248 coating agent Substances 0.000 description 10
- 238000000576 coating method Methods 0.000 description 10
- 230000003213 activating effect Effects 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 9
- 210000004185 liver Anatomy 0.000 description 9
- 210000000582 semen Anatomy 0.000 description 9
- 210000002784 stomach Anatomy 0.000 description 9
- 210000004392 genitalia Anatomy 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 206010021118 Hypotonia Diseases 0.000 description 7
- 206010003883 azoospermia Diseases 0.000 description 7
- 230000017531 blood circulation Effects 0.000 description 7
- 208000017561 flaccidity Diseases 0.000 description 7
- 239000008187 granular material Substances 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 7
- 208000008634 oligospermia Diseases 0.000 description 7
- 230000036616 oligospermia Effects 0.000 description 7
- 231100000528 oligospermia Toxicity 0.000 description 7
- 102100033902 Endothelin-1 Human genes 0.000 description 6
- 101800004490 Endothelin-1 Proteins 0.000 description 6
- 208000004880 Polyuria Diseases 0.000 description 6
- 230000005856 abnormality Effects 0.000 description 6
- 230000035619 diuresis Effects 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- 230000001717 pathogenic effect Effects 0.000 description 6
- 230000018052 penile erection Effects 0.000 description 6
- 230000035946 sexual desire Effects 0.000 description 6
- 230000002159 abnormal effect Effects 0.000 description 5
- 230000033001 locomotion Effects 0.000 description 5
- 206010007247 Carbuncle Diseases 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 4
- 241000721047 Danaus plexippus Species 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- 241000219050 Polygonaceae Species 0.000 description 4
- 240000001341 Reynoutria japonica Species 0.000 description 4
- 235000018167 Reynoutria japonica Nutrition 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- 238000005520 cutting process Methods 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000007689 inspection Methods 0.000 description 4
- 238000010926 purge Methods 0.000 description 4
- BNRNXUUZRGQAQC-UHFFFAOYSA-N sildenafil Chemical group CCCC1=NN(C)C(C(N2)=O)=C1N=C2C(C(=CC=1)OCC)=CC=1S(=O)(=O)N1CCN(C)CC1 BNRNXUUZRGQAQC-UHFFFAOYSA-N 0.000 description 4
- 230000019100 sperm motility Effects 0.000 description 4
- 210000001550 testis Anatomy 0.000 description 4
- 230000004087 circulation Effects 0.000 description 3
- 238000002405 diagnostic procedure Methods 0.000 description 3
- 210000003090 iliac artery Anatomy 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- 239000002504 physiological saline solution Substances 0.000 description 3
- 239000008517 radix Trichosanthis Substances 0.000 description 3
- 210000004706 scrotum Anatomy 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- MUKYLHIZBOASDM-UHFFFAOYSA-N 2-[carbamimidoyl(methyl)amino]acetic acid 2,3,4,5,6-pentahydroxyhexanoic acid Chemical compound NC(=N)N(C)CC(O)=O.OCC(O)C(O)C(O)C(O)C(O)=O MUKYLHIZBOASDM-UHFFFAOYSA-N 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 241000208838 Asteraceae Species 0.000 description 2
- 206010067162 Asthenospermia Diseases 0.000 description 2
- 208000007799 Asthenozoospermia Diseases 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 241000915582 Clematis manshurica Species 0.000 description 2
- 235000007354 Coix lacryma jobi Nutrition 0.000 description 2
- 241000220485 Fabaceae Species 0.000 description 2
- 241000202807 Glycyrrhiza Species 0.000 description 2
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 2
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 2
- 240000008917 Glycyrrhiza uralensis Species 0.000 description 2
- 235000017443 Hedysarum boreale Nutrition 0.000 description 2
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010049949 Intercostal neuralgia Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 208000007466 Male Infertility Diseases 0.000 description 2
- 241000209504 Poaceae Species 0.000 description 2
- 241000218201 Ranunculaceae Species 0.000 description 2
- 235000008090 Rheum palmatum Nutrition 0.000 description 2
- 240000001745 Rheum palmatum Species 0.000 description 2
- 241000117268 Sigesbeckia glabrescens Species 0.000 description 2
- 240000003801 Sigesbeckia orientalis Species 0.000 description 2
- 235000003407 Sigesbeckia orientalis Nutrition 0.000 description 2
- 206010042674 Swelling Diseases 0.000 description 2
- 241000159213 Zygophyllaceae Species 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 238000007605 air drying Methods 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 210000005226 corpus cavernosum Anatomy 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 210000002889 endothelial cell Anatomy 0.000 description 2
- 210000000918 epididymis Anatomy 0.000 description 2
- 201000010063 epididymitis Diseases 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- IIQSJHUEZBTSAT-VMPREFPWSA-N fangchinoline Chemical compound C([C@H]1C=2C=C(C(=CC=2CCN1C)OC)O1)C(C=C2)=CC=C2OC(=C2)C(OC)=CC=C2C[C@@H]2N(C)CCC3=CC(OC)=C(O)C1=C23 IIQSJHUEZBTSAT-VMPREFPWSA-N 0.000 description 2
- IIQSJHUEZBTSAT-UHFFFAOYSA-N fangchinoline Natural products O1C(C(=CC=2CCN3C)OC)=CC=2C3CC(C=C2)=CC=C2OC(=C2)C(OC)=CC=C2CC2N(C)CCC3=CC(OC)=C(O)C1=C23 IIQSJHUEZBTSAT-UHFFFAOYSA-N 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 229940010454 licorice Drugs 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 201000008383 nephritis Diseases 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000002040 relaxant effect Effects 0.000 description 2
- 201000005404 rubella Diseases 0.000 description 2
- 235000009165 saligot Nutrition 0.000 description 2
- 230000005659 seminal clot liquefaction Effects 0.000 description 2
- 229960003310 sildenafil Drugs 0.000 description 2
- 210000002460 smooth muscle Anatomy 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 235000019605 sweet taste sensations Nutrition 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 231100000167 toxic agent Toxicity 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 208000019206 urinary tract infection Diseases 0.000 description 2
- 206010063659 Aversion Diseases 0.000 description 1
- 241000241550 Cyathula Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010062519 Poor quality sleep Diseases 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 206010047139 Vasoconstriction Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000009986 erectile function Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 235000009200 high fat diet Nutrition 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 239000002590 phosphodiesterase V inhibitor Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000004648 relaxation of smooth muscle Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000025033 vasoconstriction Effects 0.000 description 1
- 210000002417 xiphoid bone Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/59—Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
- A61K36/575—Magnolia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/716—Clematis (leather flower)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8994—Coix (Job's tears)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gynecology & Obstetrics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Endocrinology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明提供了一种化湿通痹的中药组合物,由以下重量份的药材制成:防己10份、炒薏苡仁30份、虎杖10份、豨莶草10份、威灵仙10份、厚朴10份、酒大黄6份、生甘草6份。本发明基于“因痹致痿”理论,提供一种化湿通痹的中药组合物,从较为新颖的理念治疗勃起功能障碍;本发明的化湿通痹的中药组合物符合中医辨证,科学合理,具有配伍独到、疗效显著且无毒副作用的特点,可用于治疗湿热蕴脾型阳痿,为治疗阳痿提供一种新的选择与思路。
Description
技术领域
本发明属于中药技术领域,具体涉及一种化湿通痹的中药组合物。
背景技术
勃起功能障碍(ED)是指阴茎持续不能达到或维持足够的勃起以完成满意的性生活,且病程持续3个月以上,属中医阳痿范畴。40~70岁成年男性人群可达47.4%。近年来研究表明,ED与心血管疾病、糖尿病、高脂血症和高血压等疾病密切相关,ED是心血管疾病的早期预警信号。
ED一线治疗:磷酸二酯酶5抑制剂。优点是迅速起效,但疗效局限,不能改善全身症状,停药易复发,需长期服药。现代中医认为肝郁、湿热、肾虚、血瘀是阳痿主要致病因素,治疗多从疏肝补肾、活血清热除湿入手。阴茎海绵体内皮细胞在调节海绵体平滑肌张力方面发挥重要作用,从而影响阴茎勃起功能。一氧化氮(NO)和血浆内皮素1(ET-1)是由内皮细胞分泌,具有调节血管收缩和舒张功能的重要活性物质。NO水平下降,ET-1水平升高,会引起阴茎平滑肌舒张异常,导致ED,是目前中医药治疗勃起功能障碍的主要机制之一。
本发明鉴于《素问·痹论》“凡痹之类…,逢热则纵”和《素问·痿论》“痹而不仁,发为肉痿”等论述,提出不通和弱而不用是痹和痿的本质,痹是邪气与气血等阻滞不通,痿是功能下降,即体痹用痿。本发明创新性凝练提出阳痿“因痹致痿”病机,运用化湿通痹的中药组合物治疗湿热蕴脾型阳痿,取得良好疗效,为治疗阳痿提供新的选择与思路。
发明内容
本发明所要解决的技术问题在于针对上述现有技术的不足,提供一种化湿通痹的中药组合物,该中药组合物基于“因痹致痿”理论,从较为新颖的理念治疗勃起功能障碍,获得较好的效果。
为解决上述技术问题,本发明采用的技术方案是:一种化湿通痹的中药组合物,由以下重量份的药材制成:防己5~10份、炒薏苡仁15~30份、虎杖10~15份、豨莶草9~12份、威灵仙6~10份、厚朴6~10份、酒大黄3~9份、生甘草6~10份。
优选地,所述的化湿通痹的中药组合物,由以下重量份的药材制成:防己8~10份、炒薏苡仁20~30份、虎杖10~13份、豨莶草9~10份、威灵仙8~10份、厚朴8~10份、酒大黄6~9份、生甘草6~8份。
优选地,所述的化湿通痹的中药组合物,由以下重量份的药材制成:防己10份、炒薏苡仁30份、虎杖10份、豨莶草10份、威灵仙10份、厚朴10份、酒大黄6份、生甘草6份。
优选地,所述中药组合物还可以包括药学上可接受的其它辅料;所述辅料包括陈皮、天花粉、炒蒺藜、川牛膝、菟丝子等。
优选地,所述中药组合物用于治疗勃起功能障碍时调制为汤剂或颗粒剂。
本发明中原料药材的来源、药理及药效为:
防己:汉防己Stephania tetrandra S.Moore,防己科植物粉防己(即汉防己)的干燥根;性味:苦辛而寒;归经:归膀胱经、肾经、脾经;功能主治:祛风湿,止痹痛,尤以湿热为宜止痛,用于治疗风湿关节痛,肋间神经痛,急性肾炎,尿路感染。
炒薏苡仁:取禾本科植物薏米Coix lacryma-jobi L.var.mayuen(Roman.)Stapf的干燥成熟种仁,照麸炒法炒至微黄色;性味:甘淡微寒;归经:归脾、胃、肺经;功能主治:利水渗湿,健脾除痹,《神农本草经》谓之治疗“湿痹”。
厚朴:木兰科植物厚朴Magnolia officinalis Rehd.et Wils.或凹叶厚朴Magnolia officinalis Rehd.et Wils.var.biloba Rehd.et Wils.的干燥干皮、根皮及枝皮入药;性味:苦辛而温;功能主治:行气燥湿,消积平喘,《神农本草经》记载其治疗“气血痹”。
虎杖:Polygonum cuspidatum Sieb.et Zucc.,蓼科植物虎杖的干燥根茎和根;性味:苦寒;归经:归肝、胆、肺经;功能主治:清热利湿,活血通痹,用于关节痹痛,湿热黄疸,经闭,症瘕,痈肿疮毒,咳嗽痰多。
豨莶草:菊科植物毛梗豨莶Siegesbeckiaglabrescens Makino的干燥地上部分;性味:苦辛而寒;归经:肝、肾经;功能主治:祛风湿,利关节,解毒,用于治疗风湿痹痛,筋骨无力,腰膝酸软,四肢麻痹,风疹湿疮。
威灵仙:毛茛科植物东北铁线莲Clematis manshurica Rupr.的干燥根和根茎入药;性味:辛咸而温;归经:归膀胱经;功能主治:祛风湿,通经络,止痹痛,消骨梗。
酒大黄:蓼科植物掌叶大黄Rheum palmatum L.的干燥根及根茎,切厚片或块,用黄酒喷洒拌匀,微润后放锅内稍炒,取出晾干;性味:味苦,性寒;归经:归胃、脾、大肠、肝、心经;功能主治:活血行气,泻热通便,解毒消痈,行瘀通经,清热除湿,《本经》谓其能“推陈致新”。
生甘草:豆科甘草属多年草本植物甘草Glycyrrhiza uralensis Fisch.的干燥根和根茎;性味:气微,味甜;功能主治:补脾益气,健脾化湿,润肺止咳,清热解毒,调和诸药。
本发明中防己苦辛而寒,祛风湿,止痹痛,能“泻经络之湿邪”化湿通痹,热为“因痹致痿”关键,《神农本草经》谓之主“热气”,是为君药;臣以炒薏苡仁健脾渗湿,除痹,厚朴行气燥湿,《神农本草经》谓薏苡仁主“风湿痹”,厚朴治“气血痹”,二者活血行气,清热化湿通痹,助君药清热除湿通痹;佐以虎杖清热利湿活血,豨莶草治“久渗湿痹”,威灵仙“通利经络”,酒大黄可“推陈致新”,泻热活血通经,四药增强君药、臣药清热祛湿,活血通痹之功;生甘草健脾胃,调和诸药,为使药;诸药共成相须、相使的配伍关系。
本发明与现有技术相比具有以下优点:
1、本发明基于“因痹致痿”理论,提供一种化湿通痹的中药组合物,从较为新颖的理念治疗勃起功能障碍,获得较好的效果。
2、本发明的化湿通痹的中药组合物可用于治疗湿热蕴脾型阳痿和少弱精子症,为治疗阳痿和少弱精子症提供一种新的选择与思路;临床应用表明本发明的中药组合物治疗勃起功能障碍和少弱精子症具有一定疗效。
3、本发明的化湿通痹的中药组合物符合中医辨证,科学合理,具有配伍独到、疗效显著且无毒副作用的特点。
下面结合实施例对本发明作进一步详细说明。
具体实施方式
下面通过实施例进一步说明本发明。应该理解的是,本发明的实施例是用于说明本发明而不是对本发明的限制。根据本发明的实质对本发明进行的简单改进都属于本发明要求保护的范围。
为了便于理解,此处附上各种原料药材的来源、药理及药效:
防己:汉防己Stephania tetrandra S.Moore,防己科植物粉防己(即汉防己)的干燥根;性味:苦辛而寒;归经:归膀胱经、肾经、脾经;功能主治:祛风湿,止痹痛,尤以湿热为宜止痛,用于治疗风湿关节痛,肋间神经痛,急性肾炎,尿路感染。
炒薏苡仁:取禾本科植物薏米Coix lacryma-jobi L.var.mayuen(Roman.)Stapf的干燥成熟种仁,照麸炒法炒至微黄色;性味:甘淡微寒;归经:归脾、胃、肺经;功能主治:利水渗湿,健脾除痹,《神农本草经》谓之治疗“湿痹”。
厚朴:木兰科植物厚朴Magnolia officinalis Rehd.et Wils.或凹叶厚朴Magnolia officinalis Rehd.et Wils.var.biloba Rehd.et Wils.的干燥干皮、根皮及枝皮入药;性味:苦辛而温;功能主治:行气燥湿,消积平喘,《神农本草经》记载其治疗“气血痹”。
虎杖:Polygonum cuspidatum Sieb.et Zucc.,蓼科植物虎杖的干燥根茎和根;性味:苦寒;归经:归肝、胆、肺经;功能主治:清热利湿,活血通痹,用于关节痹痛,湿热黄疸,经闭,症瘕,痈肿疮毒,咳嗽痰多。
豨莶草:菊科植物毛梗豨莶Siegesbeckiaglabrescens Makino的干燥地上部分;性味:苦辛而寒;归经:肝、肾经;功能主治:祛风湿,利关节,解毒,用于治疗风湿痹痛,筋骨无力,腰膝酸软,四肢麻痹,风疹湿疮。
威灵仙:毛茛科植物东北铁线莲Clematis manshurica Rupr.的干燥根和根茎入药;性味:辛咸而温;归经:归膀胱经;功能主治:祛风湿,通经络,止痹痛,消骨梗。
酒大黄:蓼科植物掌叶大黄Rheum palmatum L.的干燥根及根茎,切厚片或块,用黄酒喷洒拌匀,微润后放锅内稍炒,取出晾干;性味:味苦,性寒;归经:归胃、脾、大肠、肝、心经;功能主治:活血行气,泻热通便,解毒消痈,行瘀通经,清热除湿,《本经》谓其能“推陈致新”。
生甘草:豆科甘草属多年草本植物甘草Glycyrrhiza uralensis Fisch.的干燥根和根茎;性味:气微,味甜;功能主治:补脾益气,健脾化湿,润肺止咳,清热解毒,调和诸药。
本发明中防己苦辛而寒,祛风湿,止痹痛,能“泻经络之湿邪”化湿通痹,热为“因痹致痿”关键,《神农本草经》谓之主“热气”,是为君药;臣以炒薏苡仁健脾渗湿,除痹,厚朴行气燥湿,《神农本草经》谓薏苡仁主“风湿痹”,厚朴治“气血痹”,二者活血行气,清热化湿通痹,助君药清热除湿通痹;佐以虎杖清热利湿活血,豨莶草治“久渗湿痹”,威灵仙“通利经络”,酒大黄可“推陈致新”,泻热活血通经,四药增强君药、臣药清热祛湿,活血通痹之功;生甘草健脾胃,调和诸药,为使药;诸药共成相须、相使的配伍关系。
实施例1
本实施例的化湿通痹的中药组合物,由以下药材制成:防己10g、炒薏苡仁30g、虎杖10g、豨莶草10g、威灵仙10g、厚朴10g、酒大黄6g、生甘草6g。本实施例的化湿通痹的中药组合物用于阳痿的临床治疗:
初诊:主诉:阴茎勃起不佳3年,加重1个月。3年前阴茎勃起硬度下降,性生活中途疲软。1个月前无法勃起,性欲下降。右侧睾丸隐痛。平素感觉脘腹痞闷,大便粘。舌体胖大有齿痕,脉数。检查:外生殖器和第二性征均未见异常。中医诊断:阳痿(湿热蕴脾证),西医诊断:勃起功能障碍,治疗:防己10g,炒薏苡仁30g,虎杖10g,豨莶草10g,威灵仙10g,厚朴10g,酒大黄6g,生甘草6g。14付(1付2袋,由医院颗粒药房制作为颗粒剂),餐后温水冲服,早晚各一袋。
二诊:患者诉服药后自觉身上热,热气由体内向外透发感,时值冬季,畏寒较往年明显减轻。整体状态改善。睡眠浅,多梦。治疗:原方继服14付。
随访患者诉性交过程中阴茎未疲软,性欲明显改善。右侧睾丸疼痛消失。睡眠改善。
实施例2
本实施例的化湿通痹的中药组合物,由以下药材制成:防己10g、炒薏苡仁20g、虎杖13g、豨莶草12g、威灵仙10g、厚朴6g、酒大黄3g、生甘草10g。本实施例的化湿通痹的中药组合物用于阳痿的临床治疗:
初诊:主诉:阴茎勃起不佳1年余。阴茎勃起速度和硬度下降1年余,性交过程中容易疲软,有时因为疲软无法完成射精,性欲下降。叩击右季肋区可引起剑突下闷胀感。舌红,舌中与舌根部苔黄腻,脉滑。检查:外生殖器和第二性征均未见异常。中医诊断:阳痿(湿热蕴脾证),西医诊断:勃起功能障碍,治疗:防己10g、炒薏苡仁20g、虎杖13g、豨莶草12g、威灵仙10g、厚朴6g、酒大黄3g、生甘草10g。14付(1付2袋,1袋200mL),水煎餐后温服,早晚各一袋。
二诊:阴茎勃起速度改善较明显,勃起硬度略有提升。治疗:原方继服14付。
随访患者诉阴茎勃起速度明显改善,性交过程中阴茎疲软明显改善,均正常射精,性欲提升。舌苔黄腻改善。
实施例3
本实施例的化湿通痹的中药组合物,由以下药材制成:防己10g、炒薏苡仁20g、虎杖15g、豨莶草10g、威灵仙10g、厚朴6g、酒大黄9g、生甘草6g。本实施例的化湿通痹的中药组合物用于阳痿的临床治疗:
初诊:主诉:阴茎勃起不佳1年。患者阴茎勃起硬度下降,勃起速度尚可,性生活中间疲软,疲软则不能完成射精。舌红苔白厚腻,中间有裂纹,唇色暗,脉沉,左关滑弦,右脉滑。检查:外生殖器和第二性征均未见异常。中医诊断:阳痿(湿热蕴脾证),西医诊断:勃起功能障碍,治疗:防己10g,炒薏苡仁20g,虎杖15g,豨莶草10g,威灵仙10g,厚朴6g,酒大黄9g,生甘草6g。14付(1付2袋,由医院颗粒药房制作为颗粒剂),餐后温水冲服,早晚各一袋。
二诊:阴茎勃起硬度明显提升,性交过程中阴茎疲软改善,能完成射精。舌苔厚腻改善。治疗:原方继服14付。
随访患者诉性生活时阴茎硬度明显提升,性交过程中阴茎疲软消失,正常射精。舌淡红苔薄白湿润。
实施例4
本实施例的化湿通痹的中药组合物,由以下药材制成:防己10g、炒薏苡仁30g、虎杖10g、豨莶草10g、威灵仙10g、厚朴10g、酒大黄6g、生甘草6g。本实施例的化湿通痹的中药组合物用于阳痿的临床治疗:
初诊:主诉:阴茎勃起速度明显下降。患者性生活时阴茎勃起速度下降,性交过程中阴茎易疲软。舌红苔黄腻,舌质干少津。检查:外生殖器和第二性征均未见异常。中医诊断:阳痿(湿热蕴脾证),西医诊断:勃起功能障碍,治疗:防己10g,炒薏苡仁30g,虎杖10g,豨莶草10g,威灵仙10g,厚朴10g,酒大黄6g,生甘草6g,陈皮6g,天花粉10g。14付(1付2袋,1袋200mL),水煎餐后温服,早晚各一袋。加陈皮理气,助气运行水湿,天花粉生津。
二诊:阴茎勃起速度与硬度均明显提升。舌红苔腻微黄,质干。治疗:原方继服14付。
随访患者诉阴茎勃起硬度持续时间提升,自觉勃起状态较看病前明显改善,性生活满意。
实施例5
本实施例的化湿通痹的中药组合物,由以下药材制成:防己5g、炒薏苡仁30g、虎杖10g、豨莶草9g、威灵仙10g、厚朴10g、酒大黄6g、生甘草6g。本实施例的化湿通痹的中药组合物用于阳痿的临床治疗:
初诊:主诉:阴茎勃起速度下降,性欲低半年余。患者性生活时阴茎勃起速度下降半年余,性交过程中阴茎易疲软。平素易疲乏,便溏。血压偏高。舌红苔黄腻。检查:外生殖器和第二性征均未见异常。中医诊断:阳痿(湿热蕴脾证),西医诊断:勃起功能障碍,治疗:防己5g,炒薏苡仁30g,虎杖10g,豨莶草9g,威灵仙10g,厚朴10g,酒大黄6g,生甘草6g,炒蒺藜10g。14付(1付2袋,由医院颗粒药房制作为颗粒剂),餐后温水冲服,早晚各一袋。加炒蒺藜降压,益气轻身。
二诊:阴茎勃起速度明显提升,性交过程中阴茎疲软消失。大便已成形。舌苔微黄腻。治疗:原方继服14付。
三诊:阴茎勃起速度与性欲均提升,自觉满意。治疗:原方继服14付。
随访患者诉勃起功能基本正常,性交过程中阴茎疲软消失。
实施例6
本实施例的化湿通痹的中药组合物,由以下药材制成:防己10g、炒薏苡仁30g、虎杖15g、豨莶草10g、威灵仙8g、厚朴8g、酒大黄6g、生甘草8g。本实施例的化湿通痹的中药组合物用于阳痿的临床治疗:
初诊:主诉:阴茎勃起不佳3个月余。患者阴茎勃起硬度和速度下降,性欲低。阴囊潮湿发凉2年余,腰酸痛。检查:外生殖器和第二性征均未见异常。中医诊断:阳痿(湿热蕴脾证),西医诊断:勃起功能障碍,治疗:防己10g、炒薏苡仁30g、虎杖15g、豨莶草10g、威灵仙8g、厚朴8g、酒大黄6g、生甘草8g。14付(1付2袋,1袋200mL),水煎餐后温服,早晚各一袋。
二诊:阴茎勃起速度与硬度改善,性欲改善,阴囊潮湿减轻。治疗:原方继服14付。
三诊:患者勃起速度与硬度恢复如前,性欲明显改善,阴囊潮湿消失。
随访患者诉勃起功能基本正常,双方性生活满意。
实施例7
本实施例的化湿通痹的中药组合物,由以下药材制成:防己8g、炒薏苡仁15g、虎杖10g、豨莶草12g、威灵仙6g、厚朴9g、酒大黄7g、生甘草7g。本实施例的化湿通痹的中药组合物用于少弱精子症的临床治疗:
初诊:患者育有1女,现备孕而求进一步诊治。中医四诊未见明显症状与体征。舌红苔白腻。检查:外生殖器和第二性征均未见异常,睾丸、附睾未见异常。精液常规检查:前向运动(PR):7.36%,精子总活力(PR+NP):25.58%,精子浓度:202.26百万/毫升。中医诊断:无子(湿热蕴脾证),西医诊断:男性不育(弱精症),治疗:防己8g、炒薏苡仁15g、虎杖10g、豨莶草12g、威灵仙6g、厚朴9g、酒大黄7g、生甘草7g。14付(1付2袋,1袋200mL),水煎餐后温服,早晚各一袋。
二诊:服药后无明显不适。治疗:原方继服14付。
三诊:服药后无明显不适。治疗:原方继服14付。
四诊:精液常规检查:前向运动(PR):33%,非前向运动(NP):25%,精子总活力(PR+NP):58%,精子浓度:246百万/毫升。
约2个月后随访得知女方已妊娠。
实施例8
本实施例的化湿通痹的中药组合物,由以下药材制成:防己10g、炒薏苡仁20g、虎杖12g、豨莶草10g、威灵仙10g、厚朴10g、酒大黄6g、生甘草10g。本实施例的化湿通痹的中药组合物用于少弱精子症的临床治疗:
初诊:检查:外生殖器和第二性征均未见异常,睾丸、附睾未见异常。精液常规检查:前向运动(PR)0.0%,精子总活力(PR+NP)10.08%,精子正常形态率2.5%。精液液化不良。中医诊断:无子(湿热蕴脾证),西医诊断:男性不育(弱精症),治疗:防己10g,炒薏苡仁20g,虎杖12g,豨莶草10g,威灵仙10g,厚朴10g,酒大黄6g,生甘草10g,川牛膝10g,菟丝子6g。14付(1付2袋,1袋200mL),水煎餐后温服,早晚各一袋。加川牛膝、菟丝子增强补肝肾,活血通痹之力。
二诊:服药后无明显不适。治疗:原方继服14付。
三诊:服药后无明显不适。治疗:原方继服14付。
四诊:精液常规检查:前向运动(PR):2.71%,非前向运动(NP):19.46%,精子总活力(PR+NP):22.17%,精子正常率3%。精液液化正常。
实施例9
利用本发明的化湿通痹的中药组合物,开展大鼠实验:
空白对照组不施加干预;
模型组为高脂饲料喂养和髂内动脉结扎术处理,模拟人体发病机制;用5mL生理盐水灌胃,每日1次;
假手术组只饲养高脂饲料,不结扎髂内动脉;用5mL生理盐水灌胃,每日1次;
西地那非组为西地那非治疗组,4.5mg/kg/日,相当于临床用药剂量,根据大鼠体重计算药量,溶于5mL生理盐水灌胃,每日1次;
化湿通痹的中药组合物配方为:防己10g、炒薏苡仁30g、虎杖10g、豨莶草10g、威灵仙10g、厚朴10g、酒大黄6g、生甘草6g;以低、中、高剂量分别治疗大鼠。其中,中药组合物低剂量组:3.24g/kg/日,相当于临床用药剂量的1/2,根据大鼠体重计算药量,溶于5mL清水灌胃,每日1次;中药组合物中剂量组:6.48g/kg/日,相当于临床用药剂量,根据大鼠体重计算药量,溶于5mL清水灌胃,每日1次;中药组合物高剂量组:12.96g/kg/日,相当于临床用药剂量的2倍,根据大鼠体重计算药量,溶于5mL清水灌胃,每日1次。
治疗效果结果如下:
表1大鼠的勃起功能障碍(ED)治疗实验数据
注:与模型组比较#P<0.05,与空白对照组比较*P<0.05,与假手术组比较△P<0.05。
表1的大鼠实验数据表明:模型组的高脂饲料喂养和髂内动脉结扎术处理成功模拟了勃起功能障碍(ED)疾病;实验中的各组治疗对大鼠的勃起功能障碍均有效,其中,化湿通痹的中药组合物中剂量组的治疗效果最好。
表2大鼠血清NO浓度与ET-1浓度
注:与模型组比较#P<0.05,与空白对照组比较*P<0.05。
表2的实验数据表明:本发明的化湿通痹的中药组合物能明显提高患有勃起功能障碍(ED)大鼠血清内NO的浓度水平,促进NO释放;且能明显降低患有勃起功能障碍(ED)大鼠血清内ET-1的浓度水平。因此,本发明的化湿通痹的中药组合物对NO和ET-1水平的调节有助于阴茎海绵体平滑肌舒张,改善阴茎勃起功能,发挥治疗ED的作用。
以上所述,仅是本发明的较佳实施例,并非对本发明作任何限制。凡是根据发明技术实质对以上实施例所作的任何简单修改、变更以及等效变化,均仍属于本发明技术方案的保护范围内。
Claims (4)
1.一种化湿通痹的中药组合物,其特征在于,由以下重量份的药材制成:防己5~10份、炒薏苡仁15~30份、虎杖10~15份、豨莶草9~12份、威灵仙6~10份、厚朴6~10份、酒大黄3~9份、生甘草6~10份。
2.根据权利要求1所述的一种化湿通痹的中药组合物,其特征在于,由以下重量份的药材制成:防己8~10份、炒薏苡仁20~30份、虎杖10~13份、豨莶草9~10份、威灵仙8~10份、厚朴8~10份、酒大黄6~9份、生甘草6~8份。
3.根据权利要求2所述的一种化湿通痹的中药组合物,其特征在于,由以下重量份的药材制成:防己10份、炒薏苡仁30份、虎杖10份、豨莶草10份、威灵仙10份、厚朴10份、酒大黄6份、生甘草6份。
4.根据权利要求1~3任一权利要求所述的一种化湿通痹的中药组合物,其特征在于,所述中药组合物还可以包括药学上可接受的其它辅料。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310801214.8A CN116650599B (zh) | 2023-07-03 | 2023-07-03 | 一种化湿通痹的中药组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310801214.8A CN116650599B (zh) | 2023-07-03 | 2023-07-03 | 一种化湿通痹的中药组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN116650599A true CN116650599A (zh) | 2023-08-29 |
CN116650599B CN116650599B (zh) | 2024-09-20 |
Family
ID=87722550
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310801214.8A Active CN116650599B (zh) | 2023-07-03 | 2023-07-03 | 一种化湿通痹的中药组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116650599B (zh) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108272999A (zh) * | 2018-05-03 | 2018-07-13 | 高庆泽 | 一种治疗阳痿的中药剂及其制备方法 |
-
2023
- 2023-07-03 CN CN202310801214.8A patent/CN116650599B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108272999A (zh) * | 2018-05-03 | 2018-07-13 | 高庆泽 | 一种治疗阳痿的中药剂及其制备方法 |
Non-Patent Citations (2)
Title |
---|
叶梦怡;牛阳;: "三仁汤临床应用举隅", 光明中医, vol. 32, no. 06, 28 March 2017 (2017-03-28), pages 887 - 890 * |
宋春生;赵家有;: "勃起功能障碍"因痹致痿"新论", 中国性科学, vol. 26, no. 01, 15 January 2017 (2017-01-15), pages 84 - 85 * |
Also Published As
Publication number | Publication date |
---|---|
CN116650599B (zh) | 2024-09-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102416079A (zh) | 一种治疗白癜风的中成药 | |
CN103520572A (zh) | 一种用于治疗特应性皮炎的中药组合物及其制备方法 | |
CN106720815A (zh) | 一种调理前列腺疾病的石斛咖啡及其制备方法 | |
CN104491831A (zh) | 一种治疗致密性骶髂骨关节炎的中药制剂及其制备方法 | |
CN104324125B (zh) | 一种治疗慢性咽炎的中药组合物及其制备方法 | |
CN111588828A (zh) | 一种治疗新冠病毒和病毒性疾病的中药制剂及制备方法 | |
CN103330837B (zh) | 一种治疗绝经妇女骨质疏松症的中药组合物 | |
CN102430013A (zh) | 治疗白癜风的中药 | |
CN116650599B (zh) | 一种化湿通痹的中药组合物 | |
CN106362066A (zh) | 一种治疗风湿类风湿性疾病的药酒及其制备方法 | |
CN105125911A (zh) | 一种用于调治前列腺增生的中药组合物及其制备方法 | |
CN105106696A (zh) | 一种治疗慢性前列腺炎的中药组合物 | |
CN105125910A (zh) | 治疗坐骨神经痛的中药组合物及其制备方法 | |
CN104606538A (zh) | 一种用于预防和治疗糖尿病的中药保健品 | |
CN104940672A (zh) | 一种治疗胆囊结石的中药及制备方法 | |
CN110870910A (zh) | 治疗前列腺病的中药及其制备方法 | |
CN103623286A (zh) | 一种治疗生殖器疱疹的中草药 | |
CN108042744A (zh) | 一种用于治疗前列腺疾病的中药组合物及制备方法 | |
CN102274442B (zh) | 一种用于治疗痹症的鹿骨酒及其制备方法和应用 | |
CN116492412B (zh) | 一种治疗血虚络阻证末梢神经炎的中药组合物 | |
CN114796434A (zh) | 内正邪不干丸 | |
CN108714173B (zh) | 一种治疗股骨头坏死湿热瘀阻证的中药组合物、丸剂及其制备方法 | |
CN104800519A (zh) | 一种治疗冲任失调型乳腺增生的药物及其制备方法 | |
CN104922595A (zh) | 一种用于带状疱疹的中药制剂及其制备方法 | |
CN112972611A (zh) | 一种治疗溶血性贫血的药物组合物及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant |